Craig B. Thompson is a director of Regeneron Pharmaceuticals, Inc.
Person profile
Address
Kenilworth, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
15 May 24
4
REGENERON PHARMACEUTICALS, INC.
4 Jan 24
4
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
17 May 23
4
REGENERON PHARMACEUTICALS, INC.
5 Jan 23
4
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
4 Jan 23
3
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
14 Dec 22
4
REGENERON PHARMACEUTICALS, INC.
5 Oct 22
3
REGENERON PHARMACEUTICALS, INC.
5 Oct 22
4
Merck & Co., Inc.
29 May 18
4
CHARLES RIVER LABORATORIES INTERNATIONAL INC
15 May 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 May 24 | CRL Charles River Laboratories International | Common Stock | Grant | Acquire A | No | No | 228.41 | 559 | 127.68 k | 1,467 |
13 May 24 | CRL Charles River Laboratories International | Stock Options Common Stock | Grant | Acquire A | No | No | 228.41 | 1,311 | 299.45 k | 1,311 |
2 Jan 24 | REGN Regeneron Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 135 | 0.00 | 454 |
2 Jan 24 | REGN Regeneron Pharmaceuticals | NQSO Common Stock | Grant | Acquire A | No | No | 888.34 | 1,607 | 1.43 mm | 1,607 |
15 May 23 | CRL Charles River Laboratories International | Common Stock | Grant | Acquire A | No | No | 0 | 664 | 0.00 | 908 |
15 May 23 | CRL Charles River Laboratories International | Stock Options Common Stock | Grant | Acquire A | No | No | 192.36 | 1,669 | 321.05 k | 1,669 |
3 Jan 23 | CRL Charles River Laboratories International | Common Stock | Grant | Acquire A | No | No | 0 | 244 | 0.00 | 244 |
3 Jan 23 | CRL Charles River Laboratories International | Stock Options Common Stock | Grant | Acquire A | No | No | 218.4 | 592 | 129.29 k | 592 |
3 Jan 23 | REGN Regeneron Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 40 | 0.00 | 319 |
3 Jan 23 | REGN Regeneron Pharmaceuticals | NQSO Common Stock | Grant | Acquire A | No | No | 725.89 | 477 | 346.25 k | 477 |